EDGEWELL PERSONAL CARE Co (EPC) stock analysis
Close on Nov 11, 2026Market cap $1.34BP/E –Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak7 of 30 checks passed
Edgewell Personal Care passes 7 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 2/6
- Past performance
- 0/6
- Financial health
- 2/6
- Dividend
- 2/6
What stands out
Guidance raised
Edgewell Personal Care raised its full fiscal year pre-tax charges outlook on Aug 5, 2026.
Covered by free cash flow
Dividends take 54.2% of free cash flow.
P/B below the industry
Edgewell Personal Care's price-to-book of 0.92 is below the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 4.86.
Growing faster than the industry
Revenue grew 11.6% over the last twelve months; the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median is 5.9%.
What to watch
Return on equity under 15%
Return on equity was -6.2% over the last twelve months and averaged 6.0% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 0.6%, below the 10% that usually covers the cost of capital.
High debt
Debt is 85.3% of shareholders' equity, above the 40% we consider low.
Earnings shrank over 5 years
Net income shrank 17.8% a year on average over the last five fiscal years.
Valuation1/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA above its 5-year median
Edgewell Personal Care's EV/EBITDA of 21.9 is above its 5-year median of 10.3.
P/B below the industry
Edgewell Personal Care's price-to-book of 0.92 is below the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 4.86.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth2/6
Revenue growing under 10% a year
Revenue grew 0.8% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -34.1% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -244% over the last twelve months, against a 5-year average of -17.8% a year.
Growing faster than the industry
Revenue grew 11.6% over the last twelve months; the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median is 5.9%.
Guidance raised
Edgewell Personal Care raised its full fiscal year pre-tax charges outlook on Aug 5, 2026.
Gross margin slipping
Gross margin was 39.5% over the last twelve months, against 43.4% a year earlier.
Past performance0/6
Return on equity under 15%
Return on equity was -6.2% over the last twelve months and averaged 6.0% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 0.6%, below the 10% that usually covers the cost of capital.
Return on equity below the industry
Edgewell Personal Care's return on equity of -6.2% is below the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of -1.2%.
Earnings shrank over 5 years
Net income shrank 17.8% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was -4.2% over the last twelve months, against a 5-year average of 4.2%.
Net margin below the industry
Edgewell Personal Care's net margin of -4.2% is below the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 0.2%.
Financial health2/6
High debt
Debt is 85.3% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 86.0% five years ago to 85.3%.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals 9.7% of total debt; we look for at least 20%.
Interest not well covered
Operating income covers interest expense 0.3 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 1.84 times current liabilities.
Elevated bankruptcy risk
The Altman Z-score is 1.61; above 3 is the safe zone and below 1.8 the distress zone.
Dividend2/6
Pays a dividend
Edgewell Personal Care paid dividends worth 2.1% of the share price over the last twelve months.
Yield below Treasuries
The 2.1% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Edgewell Personal Care yields 2.1%.
Dividend stability
Fewer than five years of dividend history.
Earnings cover
Needs dividends paid and net income.
Covered by free cash flow
Dividends take 54.2% of free cash flow.
Fair value
How we estimate itWe don't publish a fair value for Edgewell Personal Care. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 17.7
- Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median 29.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $13.83M
- Value traded per 1% price move
- $8.49M
Downside
High risk
- Typical loss in a bad month
- 26.1%
- Volatility (annualized)
- 44%
- Sharpe ratio, 1 year
- 1.15
- Beta to the S&P 500 (5Y)
- 0.68
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -1.3% | +0.8% | +2.7% | -0.8% | |
| Gross profit | -3.2% | +1.7% | +1.0% | -2.4% | |
| Operating income | -51.5% | -19.1% | -11.3% | – | |
| Net income | -74.2% | -36.6% | -17.8% | – | |
| EPS, diluted | -73.1% | -34.1% | -15.6% | – | |
| Free cash flow | – | -3.2% | -25.9% | -1.8% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 9.7% | 4.9% | 1.6% | |
| Return on assets | 3.7% | 1.9% | 0.7% | |
| Current ratio | 1.67 | 1.93 | 1.76 | |
| Debt to equity | 1.00 | 0.86 | 0.89 | |
| Net debt to EBITDA | – | 3.30× | 6.24× | |
| Interest coverage | – | 2.9× | 1.3× | |
| Inventory turnover | 3.7× | 3.2× | 2.9× | |
| Capex to revenue | 2.9% | 2.4% | 3.5% | |
| Diluted shares | 60M | 55M | 48M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Edgewell Personal Care generated $896.50M from operations and spent $804.30M on capital expenditure, dividends and share buybacks. 37% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 1.1% | 0.59× | 2.39× | 1.6% |
| FY2024 | 4.4% | 0.60× | 2.39× | 6.3% |
| FY2023 | 5.1% | 0.60× | 2.48× | 7.6% |
| FY2022 | 4.6% | 0.59× | 2.42× | 6.5% |
| FY2021 | 5.6% | 0.58× | 2.38× | 7.8% |
| FY2020 | 3.5% | 0.56× | 2.54× | 4.9% |
| FY2019 | -17.4% | 0.58× | 2.42× | -24.4% |
| FY2018 | 4.6% | 0.55× | 2.34× | 5.9% |
| FY2017 | 0.2% | 0.51× | 2.51× | 0.3% |
| FY2016 | 7.6% | 0.48× | 2.64× | 9.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$25.40M
- Cash generatingOperating cash flow above zero$118.40M
- Return on assets improvedROA up on the prior year2.6% → 0.7%
- Earnings backed by cashOperating cash flow above net income$118.40M vs $25.40M
- Less leverageLong-term debt to assets fell34.2% → 36.8%
- Better liquidityCurrent ratio rose1.66 → 1.76
- No dilutionShare count did not rise50M → 48M
- Gross margin improvedGross margin up on the prior year42.41% → 41.60%
- More efficientAsset turnover rose0.60 → 0.60
See a number that looks wrong?